Ainos, Inc. (AIMD)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Jun 20, 2025

$0.51

P/E Ratio

N/A

Market Cap

$10.59M

Description
Add to research
View more

Ainos, Inc. is a diversified medtech company, which engages in the development of medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease indications. Its medtech solutions include COVID-19 Antigen Rapid Test Kit, VOC POCT-Ainos Flora, VOC POCT-Ainos Pen, VOC POCT-CHS430, Very Low-Dose Oral Interferon Alpha, and Synthetic RNA. The company was founded on June 26, 1984 and is headquartered in San Diego, CA.

Metrics
Add to research
View more

Overview

  • HQSan Diego, CA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerAIMD
  • Price$0.5054-7.25%

Trading Information

  • Market cap$10.59M
  • Float2.53%
  • Average Daily Volume (1m)364,144
  • Average Daily Volume (3m)256,440
  • EPS-$1.33

Company

  • Revenue$0.11M
  • Rev growth (1yr)412.36%
  • Net income-$3.29M
  • Gross margin-1,025.63%
  • EBITDA margin-1,869.56%
  • EBITDA-$1.99M
  • EV$17.16M
  • EV/Revenue161.61
  • P/EN/A
  • P/S75.49
  • P/B0.66
  • Debt/Equity91.45
Documents
Add to research
View more
Loading...